Cargando…
Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
BACKGROUND: Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, anti...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676113/ https://www.ncbi.nlm.nih.gov/pubmed/26654954 http://dx.doi.org/10.1186/s12931-015-0308-1 |
_version_ | 1782405113789284352 |
---|---|
author | Sakamoto, Noriho Kakugawa, Tomoyuki Hara, Atsuko Nakashima, Shota Yura, Hirokazu Harada, Tatsuhiko Ishimoto, Hiroshi Yatera, Kazuhiro Kuwatsuka, Yutaka Hara, Toshihide Ichinose, Kunihiro Obase, Yasushi Ishimatsu, Yuji Kohno, Shigeru Mukae, Hiroshi |
author_facet | Sakamoto, Noriho Kakugawa, Tomoyuki Hara, Atsuko Nakashima, Shota Yura, Hirokazu Harada, Tatsuhiko Ishimoto, Hiroshi Yatera, Kazuhiro Kuwatsuka, Yutaka Hara, Toshihide Ichinose, Kunihiro Obase, Yasushi Ishimatsu, Yuji Kohno, Shigeru Mukae, Hiroshi |
author_sort | Sakamoto, Noriho |
collection | PubMed |
description | BACKGROUND: Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, antimicrobial peptides that function in regulating the inflammatory response, and IL-8, a potent chemoattractant for neutrophils. The present study evaluated the levels of defensins and IL-8 in patients with SSc-ILD to determine their roles in disease pathogenesis. METHODS: Defensins (also known as human neutrophil peptides, HNPs) and IL-8 levels were measured in the serum and bronchoalveolar lavage fluid (BALF) of 33 patients with SSc-ILD and in 20 healthy controls by using ELISA. RESULTS: BALF analysis revealed a significant increase in HNPs in SSc-ILD patients (median; 240.0 pg/mL) than that of healthy controls (79.7 pg/mL). Additionally, IL-8 levels were higher in SSc-ILD patient serum and BALF as compared to healthy controls (16.4 pg/mL vs. 5.8 pg/mL and 15.4 pg/mL vs. 14.5 pg/mL, respectively). However, plasma HNPs levels were relatively unchanged. HNP and IL-8 levels in patient BALF displayed a significant positive correlation significantly correlated (r = 0.774, p <0.01), and which also correlated with clinical disease parameters—such as ILD biomarkers, pulmonary function tests, ratio of neutrophils and eosinophils in BALF, tricuspid regurgitation peak gradient (TRPG), and the extent of high-resolution computed tomography (HRCT) findings in the lung. Levels of plasma HNPs and serum IL-8 did not show a significant correlation with any clinical parameter. SSc-ILD progression was evaluated by pulmonary function tests, but no association was observed between VC change ratios and HNPs or IL-8 levels. CONCLUSIONS: BALF levels of HNPs and IL-8 were higher in SSc-ILD than in healthy controls, and are associated with various clinical disease parameters. Further studies are needed to clarify the role of defensins and IL-8 in SSc-ILD pathogenesis. |
format | Online Article Text |
id | pubmed-4676113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46761132015-12-12 Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis Sakamoto, Noriho Kakugawa, Tomoyuki Hara, Atsuko Nakashima, Shota Yura, Hirokazu Harada, Tatsuhiko Ishimoto, Hiroshi Yatera, Kazuhiro Kuwatsuka, Yutaka Hara, Toshihide Ichinose, Kunihiro Obase, Yasushi Ishimatsu, Yuji Kohno, Shigeru Mukae, Hiroshi Respir Res Research BACKGROUND: Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, antimicrobial peptides that function in regulating the inflammatory response, and IL-8, a potent chemoattractant for neutrophils. The present study evaluated the levels of defensins and IL-8 in patients with SSc-ILD to determine their roles in disease pathogenesis. METHODS: Defensins (also known as human neutrophil peptides, HNPs) and IL-8 levels were measured in the serum and bronchoalveolar lavage fluid (BALF) of 33 patients with SSc-ILD and in 20 healthy controls by using ELISA. RESULTS: BALF analysis revealed a significant increase in HNPs in SSc-ILD patients (median; 240.0 pg/mL) than that of healthy controls (79.7 pg/mL). Additionally, IL-8 levels were higher in SSc-ILD patient serum and BALF as compared to healthy controls (16.4 pg/mL vs. 5.8 pg/mL and 15.4 pg/mL vs. 14.5 pg/mL, respectively). However, plasma HNPs levels were relatively unchanged. HNP and IL-8 levels in patient BALF displayed a significant positive correlation significantly correlated (r = 0.774, p <0.01), and which also correlated with clinical disease parameters—such as ILD biomarkers, pulmonary function tests, ratio of neutrophils and eosinophils in BALF, tricuspid regurgitation peak gradient (TRPG), and the extent of high-resolution computed tomography (HRCT) findings in the lung. Levels of plasma HNPs and serum IL-8 did not show a significant correlation with any clinical parameter. SSc-ILD progression was evaluated by pulmonary function tests, but no association was observed between VC change ratios and HNPs or IL-8 levels. CONCLUSIONS: BALF levels of HNPs and IL-8 were higher in SSc-ILD than in healthy controls, and are associated with various clinical disease parameters. Further studies are needed to clarify the role of defensins and IL-8 in SSc-ILD pathogenesis. BioMed Central 2015-12-10 2015 /pmc/articles/PMC4676113/ /pubmed/26654954 http://dx.doi.org/10.1186/s12931-015-0308-1 Text en © Sakamoto et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Sakamoto, Noriho Kakugawa, Tomoyuki Hara, Atsuko Nakashima, Shota Yura, Hirokazu Harada, Tatsuhiko Ishimoto, Hiroshi Yatera, Kazuhiro Kuwatsuka, Yutaka Hara, Toshihide Ichinose, Kunihiro Obase, Yasushi Ishimatsu, Yuji Kohno, Shigeru Mukae, Hiroshi Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
title | Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
title_full | Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
title_fullStr | Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
title_full_unstemmed | Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
title_short | Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
title_sort | association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676113/ https://www.ncbi.nlm.nih.gov/pubmed/26654954 http://dx.doi.org/10.1186/s12931-015-0308-1 |
work_keys_str_mv | AT sakamotonoriho associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT kakugawatomoyuki associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT haraatsuko associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT nakashimashota associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT yurahirokazu associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT haradatatsuhiko associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT ishimotohiroshi associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT yaterakazuhiro associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT kuwatsukayutaka associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT haratoshihide associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT ichinosekunihiro associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT obaseyasushi associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT ishimatsuyuji associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT kohnoshigeru associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis AT mukaehiroshi associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis |